BiomEdit
Dharanesh Gangaiah has extensive work experience in the field of microbiome research. Dharanesh currently holds the position of Senior Director and Lead Scientist at BiomEdit, a microbiome company that focuses on discovering and developing probiotics and engineered microbial medicines for animal health. Prior to this, they worked as a Principal Research Scientist in Microbiome Research at MBRD Service Company, LLC. This company was established to facilitate the carveout of Elanco's microbiome R&D platform. Dharanesh also had a significant tenure at Elanco, where they held various roles, including Principal Research Scientist and Senior Research Scientist in Discovery Bacteriology & Microbiome. Before joining the industry, Dharanesh worked as a Postdoctoral Fellow at Indiana University School of Medicine and as a Graduate Research Associate at The Ohio State University. Dharanesh began their career as a Junior Research Fellow at G. B. Pant University Of Agriculture & Technology and as a Veterinary Intern/Student at Karnataka Veterinary, Animal & Fisheries Sciences University, Nandinagar.
Dharanesh Gangaiah's education history begins in 1999 when they enrolled at Karnataka Veterinary, Animal & Fisheries Sciences University, Nandinagar. Dharanesh pursued a Bachelor of Veterinary Science and Animal Husbandry (DVM) degree, achieving a Class Rank of #1 upon completion in 2004. Following this, they pursued further education at G. B. Pant University of Agriculture & Technology. From 2005 to 2007, they obtained a Master of Veterinary Science degree with Distinction, specializing in Veterinary Public Health. Finally, in 2007, Dharanesh Gangaiah enrolled at The Ohio State University to pursue a Ph.D. in Microbiology, which they completed in 2011, earning a Doctor of Philosophy (PhD) degree.
This person is not in any offices
BiomEdit
BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most important problems in animal agriculture and food security by leveraging the potential of themicrobiome. BiomEdit’s technology is based on a unique platform that utilizes high-throughput sequencing and data analytics to rapidly discover and screen novel probiotic species and bioactive molecules. These can then be engineered to confer thermostability, enhanced production of beneficial metabolites, or expression of immune modulating proteins. These probiotics and microbially-derived compounds represent the next generation of products designed to promote animal health without the use of antibiotics.